Stocks
Anika Therapeutics (ANIK) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -4.16 | 18.2 | 15.1 | 3.02 | -5.32 | -6.63 | ||
| Changes by years, y/y, % | -68% | -536% | -17% | -80% | -276% | -16.1% | |||
Anika Therapeutics. EBITDA US GAAP, bln rub
Anika Therapeutics. EBITDA US GAAP, changes, %
Anika Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Anika Therapeutics (ANIK) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -2.69 | -2.68 | -1.83 | 1.96 | -4.08 | -6.63 | |
| Changes by years, y/y, % | +44% | -1 181% | -93% | -93% | +52% | |||
| Changes by quarters, q/q, % | -110% | 0% | -32% | -207% | -308% | |||
